Psychopharmacologic intervention after hemorrhagic basal ganglia damage

J Neurol Sci. 2012 Nov 15;322(1-2):77-8. doi: 10.1016/j.jns.2012.06.014. Epub 2012 Jul 13.

Abstract

Traumatic brain injury (TBI) can result in cognitive and behavioral impairments such as poor attention, learning, memory and planning ability and uncontrolled crying that can be more persistent problems than the physical disabilities. Cognitive enhancers have been shown to improve cognitive and behavioral impairments in patients with hemorrhagic basal ganglia lesions as well as other forms of TBI. There is little research about the use of cognitive enhancers after hemorrhagic basal ganglia damage. We present a case of a 38 year old male who made significant recovery with the use of cognitive enhancers.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Basal Ganglia Hemorrhage / complications*
  • Basal Ganglia Hemorrhage / drug therapy*
  • Cognition Disorders / drug therapy
  • Cognition Disorders / etiology*
  • Galantamine / therapeutic use*
  • Glasgow Coma Scale
  • Humans
  • Male
  • Mental Disorders
  • Methylphenidate / therapeutic use*
  • Neuropsychological Tests
  • Nootropic Agents / therapeutic use*
  • Tomography Scanners, X-Ray Computed

Substances

  • Nootropic Agents
  • Galantamine
  • Methylphenidate